- Email: [email protected]
Patent issued toPuradyn for newfiltration technology
NEWS
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Fax: +44 (0)1865 843973 Web: www.membrane-technology.com Publisher: Greg Valero E-mail: [email protected] Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Acumen Bioscience Ltd), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society)
Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Prices: 1215 for all European countries & Iran US$1362 for all countries except Europe and Japan ¥161 385 for Japan (Prices valid until 31 December 2011) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971 Email: [email protected], or via www.membrane-technology.com. Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
12978 Digitally Produced by Mayfield Press (Oxford) Limited
2
Membrane Technology
Sartorius Stedim Biotech adds 0.08-ml capsule size to its Sartobind STIC family
S
artorius Stedim Biotech Sa of Aubagne, France, which supplies products to the bio-pharmaceuticals industry, has added the 0.08-ml Sartobind pico to its Sartobind STIC family of capsules. During antibody production, polishing is usually performed on quaternary ammonium (Q) membranes in flow-through mode, since the overall speed and productivity are higher, compared with traditional anion-exchange columns. However, the binding capacity of Q ligands is reduced at higher conductivities, so concentrated feed streams must be diluted to adequately remove contaminants such as DNA, host cell proteins, viruses and endotoxins. According to the company, the Sartobind STIC primary amine (PA) anion-exchange membrane overcomes this limitation and binds contaminants at high conductivities under high-salt conditions at up to 20 mS/cm. The salt-tolerant anion exchanger can directly process cationexchange pools without further dilution. The small membrane volume of 0.08 ml reduces material consumption during testing and virus spiking studies to reduce costs during initial development phases. All membrane adsorber capsules in the family are ‘‘plug and play” devices and can be used like filters. Validation costs are avoided because the materials are disposed of after they have been used.
Contact: Sartorius Stedim Biotech Sa, Z.I. Les Paluds. Avenue de Jouques, BP 1051, 13781 Aubagne Cedex, France. Tel: +33 442 845600, www.sartorius-stedim.com
Rugged RO system is targeted at the food and dairy industry
D
ow Water & Process Solutions (DW&PS), a business unit of US-based Dow Chemical Co, has launched Hypershell – a rugged and reliable, reverse osmosis (RO) system that helps the food and dairy industry increase production while reducing material and energy expenditure. The Hypershell product line includes a spiral-wound 8-inch (200-mm) RO and nano-
filtration (NF) membrane encased in a hard shell made from polypropylene which eliminates channelling and prevents the premature degradation and failure of the element. The product has been designed to make it easy for customers to load new elements and unload spent ones from a system, says DW&PS. According to the company, unlike conventional mesh RO membranes, the rigid, hard-shell design yields assessable, increased benefits to the customer by reducing energy costs by up to 30%, offering an upsurge in material processing of up to 10%, and superior performance and reliability throughout the product’s service life. ‘Dow Water & Process Solutions has combined three technologies in the most advanced construction ever designed – a robust RO membrane sheet, precision automated element rolling and a machined polypropylene, hard outer shell,’ commented Marlin Kinzey, Associate Marketing Director, DW&PS. ‘Hypershell improves product performance for our customers – a key element in our development efforts for the food and dairy industry.’ All Dow RO elements contain a highrejection FT30 RO membrane that is capable of processing a wide range of food and dairy streams, and is especially effective in dewatering or product concentration applications. Hypershell elements are constructed to withstand rigorous processing applications and conditions, proving enhanced toughness and durability. All materials of construction are compliant with US Food & Drug Administration indirect food-contact requirements and are suitable for use in food-processing applications in the USA. Contact: The Dow Chemical Co, Dow Water & Process Solutions, Customer Information Center, PO Box 1206, Midland, MI 48642-1206, USA. Tel: +1 989 636 9086, www.dowwatersolutions.com, www.dow.com
Patent issued to Puradyn for new filtration technology
P
uradyn Filter Technologies Inc of Boynton Beach, Florida, USA, has been granted a new patent which, it says, will extend its competitive advantage in the field of bypass oil filtration systems. This technology – covered by US Patent 8 002 973, entitled ‘Lubricant purification system’ – enables the engine’s oil filter to be integrated with the company’s bypass microfiltration product, adding ‘‘smart’’ features to an oil filtration system. The technology provides
November 2011
NEWS a platform that creates an interface with an engine’s electronic control module, which enables ‘real-time’ on-board diagnostics to be used. Joseph Vittoria, Chairman and Chief Executive Officer, Puradyn, said: ‘Our research and development division, headed by Technical Director William Jacobs, has developed a unique technology to complement our legacy and heavy-duty product lines. This patent, which results from three years of extensive research, will be the basis for our next generation of filters, which will emerge through its many inherent technical applications.’ ‘Importantly, the patent provides Puradyn with a ‘‘road map’’ to system-integrated microfiltration methods.’ Contact: Puradyn Filter Technologies Inc, 2017 High Ridge Road, Boynton Beach, FL 33426, USA. Tel: +1 561 547 9499, www.puradyn.com
Lanxess inaugurates Bitterfeld plant, with RO elements scheduled to ship in early 2012
S
peciality chemicals company Lanxess Deutschland GmbH has inaugurated its new plant in Bitterfeld, Saxony-Anhalt, Germany, which will produce membrane filtration elements. Following the completion of extensive pilot and development phases regular production is now set to begin at the facility. The first reverse osmosis (RO) membrane elements will be available on the market at the beginning of 2012, says the firm. The facility is also equipped with laboratories, logistics areas and offices to support the delivery of ready-to-use elements for RO applications worldwide. The product line of membrane filtration elements will be marketed under the brand name Lewabrane. As reported last year in Membrane Technology (April 2010, page 9), the construction of this facility marks the group’s move into a new segment of the water-treatment business. The company, which says it has invested around E30 million in this project, is planning to develop membrane filtration technology at the site. It will therefore become one of a few companies in the market that can offer expertise and products for both ion exchange and membrane filtration. RO and ion-exchange technologies are complementary and quite often are combined to obtain optimum purification results, says Lanxess.
November 2011
‘Based on our many decades of experience with ion-exchange resins, we consider our step into membrane technology as highly important in order to provide our customers with even more comprehensive desalination products and technologies in the future,’ explained Jean-Marc Vesselle, who is the global head of the ionexchange resins business unit at Lanxess. The Lewabrane element family will comprise both 4-inch (100-mm) and 8-inch (200-mm) diameter membrane elements. The product spectrum will be further extended in the future to address additional customer needs. The membranes operate according to the crossflow principle (tangential flow filtration). This mode of operation minimises fouling and extends the membrane’s operating time – increasing the period before cleaning or maintenance is required. Lanxess says that in order to enable customers to make optimum use of the new RO membrane filtration devices it will provide custom engineering design software to optimise the performance of Lewabrane membrane systems. This software is a major extension to the current Lewatit ionexchange dimensioning package. Designers of water-treatment systems will be able to move seamlessly from RO design to ion-exchange design all within the same package. This tool will be available in early 2012 to coincide with the launch of the Lewabrane membrane filtration elements. ‘The enhanced software will enable us to translate the benefits of our comprehensive product portfolio for water treatment into value-creating advantages for our customers,’ emphasised Vesselle. With increasing market demand and planned expansions in production scale, it is expected that the number of employees at the new facility will reach 50 over the next two years, and ultimately rise to 200 people. Contacts: Lanxess Deutschland GmbH, 51369 Leverkusen, Germany. Tel: +49 214 30 33333, Email: [email protected], Web: http://lanxess.com Lanxess Inc, PO Box 3001, 1265 Vidal Street South, Sarnia, Ontario N7T 7M2, Canada. Tel: +1 519 337 8251, Web: http://lanxess.ca
Pall provides solarpowered water purifiers to villages in Africa
S
olar-powered water filtration systems developed by US company Pall
In Brief KMS promotes Carlos Rodrigues Koch Membrane Systems Inc (KMS) of Wilmington, Massachusetts, USA, has promoted Carlos Rodrigues to Business Development Manager, Industrial & Life Sciences for South America. He will be responsible for all aspects of the continued development and expansion of the company’s industrial and life sciences business in the region. Rodrigues first joined KMS as a consultant and accepted a full-time position in 2008 as a technical sales and service manager. KMS says that its expansion plans in South America require local knowledge of the customers and applications, and Carlos will be a primary catalyst for this growth. EMD Millipore launches recycling programme US-based EMD Millipore, the life science division of German company Merck KgaA, has launched ‘‘ech2o’’ – a collection and recycling programme covering the firm’s laboratory water purification consumables. Each year, companies discard thousands of used water purification cartridges that are incinerated or buried in landfills. Developed in cooperation with Heritage Environmental Services Llc, one of the country’s largest environmental firms, the programme enables US-based users of EMD Millipore’s laboratory water purification systems to return exhausted cartridges for dismantling. PepsiCo business reduces its environmental footprint Frito-Lay North America, the snack foods business unit of PepsiCo Inc, recently announced that its facility in Casa Grande, Arizona, USA, has reached ‘‘near net zero’’, in terms of the effect it has on the environment. The vision was to transform an existing facility so that it would be as far ‘‘off the grid’’ as possible and run primarily on renewable energy sources and recycled water, while producing nearly zero landfill waste. The facility also installed a water recovery and reuse system that combines membrane bioreactor and low-pressure reverse osmosis technologies to recycle 50–75% of the water it uses. H2O Innovation’s Guillaume Clairet is elected to the IDA’s board of directors Canada’s H2O Innovation Inc has announced that Guillaume Clairet, the firm’s vice president of strategic business development, has been elected to the board of directors of the International Desalination Association (IDA) for a two-year mandate. The 2011–2013 term of the new board of directors officially started at the IDA World Congress 2011 on Desalination and Water Reuse, which was held recently in Perth, Australia.
Membrane Technology
3
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Fax: +44 (0)1865 843973 Web: www.membrane-technology.com Publisher: Greg Valero E-mail: [email protected] Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Acumen Bioscience Ltd), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society)
Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Prices: 1215 for all European countries & Iran US$1362 for all countries except Europe and Japan ¥161 385 for Japan (Prices valid until 31 December 2011) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971 Email: [email protected], or via www.membrane-technology.com. Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
12978 Digitally Produced by Mayfield Press (Oxford) Limited
2
Membrane Technology
Sartorius Stedim Biotech adds 0.08-ml capsule size to its Sartobind STIC family
S
artorius Stedim Biotech Sa of Aubagne, France, which supplies products to the bio-pharmaceuticals industry, has added the 0.08-ml Sartobind pico to its Sartobind STIC family of capsules. During antibody production, polishing is usually performed on quaternary ammonium (Q) membranes in flow-through mode, since the overall speed and productivity are higher, compared with traditional anion-exchange columns. However, the binding capacity of Q ligands is reduced at higher conductivities, so concentrated feed streams must be diluted to adequately remove contaminants such as DNA, host cell proteins, viruses and endotoxins. According to the company, the Sartobind STIC primary amine (PA) anion-exchange membrane overcomes this limitation and binds contaminants at high conductivities under high-salt conditions at up to 20 mS/cm. The salt-tolerant anion exchanger can directly process cationexchange pools without further dilution. The small membrane volume of 0.08 ml reduces material consumption during testing and virus spiking studies to reduce costs during initial development phases. All membrane adsorber capsules in the family are ‘‘plug and play” devices and can be used like filters. Validation costs are avoided because the materials are disposed of after they have been used.
Contact: Sartorius Stedim Biotech Sa, Z.I. Les Paluds. Avenue de Jouques, BP 1051, 13781 Aubagne Cedex, France. Tel: +33 442 845600, www.sartorius-stedim.com
Rugged RO system is targeted at the food and dairy industry
D
ow Water & Process Solutions (DW&PS), a business unit of US-based Dow Chemical Co, has launched Hypershell – a rugged and reliable, reverse osmosis (RO) system that helps the food and dairy industry increase production while reducing material and energy expenditure. The Hypershell product line includes a spiral-wound 8-inch (200-mm) RO and nano-
filtration (NF) membrane encased in a hard shell made from polypropylene which eliminates channelling and prevents the premature degradation and failure of the element. The product has been designed to make it easy for customers to load new elements and unload spent ones from a system, says DW&PS. According to the company, unlike conventional mesh RO membranes, the rigid, hard-shell design yields assessable, increased benefits to the customer by reducing energy costs by up to 30%, offering an upsurge in material processing of up to 10%, and superior performance and reliability throughout the product’s service life. ‘Dow Water & Process Solutions has combined three technologies in the most advanced construction ever designed – a robust RO membrane sheet, precision automated element rolling and a machined polypropylene, hard outer shell,’ commented Marlin Kinzey, Associate Marketing Director, DW&PS. ‘Hypershell improves product performance for our customers – a key element in our development efforts for the food and dairy industry.’ All Dow RO elements contain a highrejection FT30 RO membrane that is capable of processing a wide range of food and dairy streams, and is especially effective in dewatering or product concentration applications. Hypershell elements are constructed to withstand rigorous processing applications and conditions, proving enhanced toughness and durability. All materials of construction are compliant with US Food & Drug Administration indirect food-contact requirements and are suitable for use in food-processing applications in the USA. Contact: The Dow Chemical Co, Dow Water & Process Solutions, Customer Information Center, PO Box 1206, Midland, MI 48642-1206, USA. Tel: +1 989 636 9086, www.dowwatersolutions.com, www.dow.com
Patent issued to Puradyn for new filtration technology
P
uradyn Filter Technologies Inc of Boynton Beach, Florida, USA, has been granted a new patent which, it says, will extend its competitive advantage in the field of bypass oil filtration systems. This technology – covered by US Patent 8 002 973, entitled ‘Lubricant purification system’ – enables the engine’s oil filter to be integrated with the company’s bypass microfiltration product, adding ‘‘smart’’ features to an oil filtration system. The technology provides
November 2011
NEWS a platform that creates an interface with an engine’s electronic control module, which enables ‘real-time’ on-board diagnostics to be used. Joseph Vittoria, Chairman and Chief Executive Officer, Puradyn, said: ‘Our research and development division, headed by Technical Director William Jacobs, has developed a unique technology to complement our legacy and heavy-duty product lines. This patent, which results from three years of extensive research, will be the basis for our next generation of filters, which will emerge through its many inherent technical applications.’ ‘Importantly, the patent provides Puradyn with a ‘‘road map’’ to system-integrated microfiltration methods.’ Contact: Puradyn Filter Technologies Inc, 2017 High Ridge Road, Boynton Beach, FL 33426, USA. Tel: +1 561 547 9499, www.puradyn.com
Lanxess inaugurates Bitterfeld plant, with RO elements scheduled to ship in early 2012
S
peciality chemicals company Lanxess Deutschland GmbH has inaugurated its new plant in Bitterfeld, Saxony-Anhalt, Germany, which will produce membrane filtration elements. Following the completion of extensive pilot and development phases regular production is now set to begin at the facility. The first reverse osmosis (RO) membrane elements will be available on the market at the beginning of 2012, says the firm. The facility is also equipped with laboratories, logistics areas and offices to support the delivery of ready-to-use elements for RO applications worldwide. The product line of membrane filtration elements will be marketed under the brand name Lewabrane. As reported last year in Membrane Technology (April 2010, page 9), the construction of this facility marks the group’s move into a new segment of the water-treatment business. The company, which says it has invested around E30 million in this project, is planning to develop membrane filtration technology at the site. It will therefore become one of a few companies in the market that can offer expertise and products for both ion exchange and membrane filtration. RO and ion-exchange technologies are complementary and quite often are combined to obtain optimum purification results, says Lanxess.
November 2011
‘Based on our many decades of experience with ion-exchange resins, we consider our step into membrane technology as highly important in order to provide our customers with even more comprehensive desalination products and technologies in the future,’ explained Jean-Marc Vesselle, who is the global head of the ionexchange resins business unit at Lanxess. The Lewabrane element family will comprise both 4-inch (100-mm) and 8-inch (200-mm) diameter membrane elements. The product spectrum will be further extended in the future to address additional customer needs. The membranes operate according to the crossflow principle (tangential flow filtration). This mode of operation minimises fouling and extends the membrane’s operating time – increasing the period before cleaning or maintenance is required. Lanxess says that in order to enable customers to make optimum use of the new RO membrane filtration devices it will provide custom engineering design software to optimise the performance of Lewabrane membrane systems. This software is a major extension to the current Lewatit ionexchange dimensioning package. Designers of water-treatment systems will be able to move seamlessly from RO design to ion-exchange design all within the same package. This tool will be available in early 2012 to coincide with the launch of the Lewabrane membrane filtration elements. ‘The enhanced software will enable us to translate the benefits of our comprehensive product portfolio for water treatment into value-creating advantages for our customers,’ emphasised Vesselle. With increasing market demand and planned expansions in production scale, it is expected that the number of employees at the new facility will reach 50 over the next two years, and ultimately rise to 200 people. Contacts: Lanxess Deutschland GmbH, 51369 Leverkusen, Germany. Tel: +49 214 30 33333, Email: [email protected], Web: http://lanxess.com Lanxess Inc, PO Box 3001, 1265 Vidal Street South, Sarnia, Ontario N7T 7M2, Canada. Tel: +1 519 337 8251, Web: http://lanxess.ca
Pall provides solarpowered water purifiers to villages in Africa
S
olar-powered water filtration systems developed by US company Pall
In Brief KMS promotes Carlos Rodrigues Koch Membrane Systems Inc (KMS) of Wilmington, Massachusetts, USA, has promoted Carlos Rodrigues to Business Development Manager, Industrial & Life Sciences for South America. He will be responsible for all aspects of the continued development and expansion of the company’s industrial and life sciences business in the region. Rodrigues first joined KMS as a consultant and accepted a full-time position in 2008 as a technical sales and service manager. KMS says that its expansion plans in South America require local knowledge of the customers and applications, and Carlos will be a primary catalyst for this growth. EMD Millipore launches recycling programme US-based EMD Millipore, the life science division of German company Merck KgaA, has launched ‘‘ech2o’’ – a collection and recycling programme covering the firm’s laboratory water purification consumables. Each year, companies discard thousands of used water purification cartridges that are incinerated or buried in landfills. Developed in cooperation with Heritage Environmental Services Llc, one of the country’s largest environmental firms, the programme enables US-based users of EMD Millipore’s laboratory water purification systems to return exhausted cartridges for dismantling. PepsiCo business reduces its environmental footprint Frito-Lay North America, the snack foods business unit of PepsiCo Inc, recently announced that its facility in Casa Grande, Arizona, USA, has reached ‘‘near net zero’’, in terms of the effect it has on the environment. The vision was to transform an existing facility so that it would be as far ‘‘off the grid’’ as possible and run primarily on renewable energy sources and recycled water, while producing nearly zero landfill waste. The facility also installed a water recovery and reuse system that combines membrane bioreactor and low-pressure reverse osmosis technologies to recycle 50–75% of the water it uses. H2O Innovation’s Guillaume Clairet is elected to the IDA’s board of directors Canada’s H2O Innovation Inc has announced that Guillaume Clairet, the firm’s vice president of strategic business development, has been elected to the board of directors of the International Desalination Association (IDA) for a two-year mandate. The 2011–2013 term of the new board of directors officially started at the IDA World Congress 2011 on Desalination and Water Reuse, which was held recently in Perth, Australia.
Membrane Technology
3